Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease
CE Samuel - Journal of Biological Chemistry, 2023 - ASBMB
A novel coronavirus now known as SARS-CoV-2 emerged in late 2019, possibly following a
zoonotic crossover from a coronavirus present in bats. This virus was identified as the …
zoonotic crossover from a coronavirus present in bats. This virus was identified as the …
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
G Bellucci, A Albanese, C Rizzi, V Rinaldi… - Frontiers in …, 2023 - frontiersin.org
Interferon-beta (IFN-β) for Multiple Sclerosis (MS) is turning 30. The COVID-19 pandemic
rejuvenated the interest in interferon biology in health and disease, opening translational …
rejuvenated the interest in interferon biology in health and disease, opening translational …
Comparison of plasma mitochondrial DNA copy number in asymptomatic and symptomatic COVID-19 patients
S Shoraka, SR Mohebbi, SM Hosseini… - Frontiers in …, 2023 - frontiersin.org
Introduction Since the beginning of the COVID-19 pandemic, a wide clinical spectrum, from
asymptomatic infection to mild or severe disease and death, have been reported in COVID …
asymptomatic infection to mild or severe disease and death, have been reported in COVID …